CTOR vs ED · $105.2M cap vs P/E 18, rev $15.26B
Citius Oncology, Inc. (CTOR) versus Consolidated Edison Inc (ED) — a side-by-side from cached financials, not a winner call.
Citius Oncology, Inc. (CTOR) is a drug manufacturers - specialty & generic company listed on US.
Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.
CTOR does not have a complete income-statement cache yet.
Latest reported ED revenue for 2024-12-31 was $15.26B. Net income was $1.82B. Revenue was up 4.0% from 2023-12-31 to 2024-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.
CTOR currently screens at market cap $105.2M. ED currently screens at market cap $36.02B and trailing P/E 18.3.
Not investment advice. Open the CTOR and ED stock pages for the full models.
Not investment advice.